Business & regional news

Study shows 67% mean reduction in Low-back Visual Analog Scale (VAS) pain score at 12 months; 87% of subjects had meaningful improvements in three or more quality of life (QoL) domains

Data to be presented at the North American Neuromodulation Society (NANS) Annual Meeting 2025; In all, Medtronic to highlight 22 poster and oral scientific data presentations

Data include durability of PulseSelect integrated with the Affera system, same day discharge and zero fluoroscopy with Affera and Sphere-9™ Catheter

Highlights underscore positive momentum of commercial launch of Affera in the U.S. and continued strong adoption of PulseSelect globally

Real-world use continues to demonstrate safety, efficacy and efficiency of both PFA technologies amid global expansion

DEFINE AFib results at AF Symposium 2025: First-of-its-kind app-based study uses AF burden data to identify patients at high risk for AF-related healthcare utilization

LINQ™ insertable cardiac monitors showed 4 times greater episode sensitivity compared to Apple Watch™*

Medtronic, a global leader in healthcare technology, announced that it has received the prestigious Great Place to Work® certification in the mid-size organization...

Agreement includes option to acquire the company

Harmony™ Transcatheter Pulmonary Valve system approval expands minimally invasive treatment options for patients with congenital heart disease across European Union

Patients can access advanced gastrointestinal care either in clinical settings or from the comfort of their home.

Two data releases at London Valves 2024 build on Evolut’s legacy of valve design and performance: Optimize PRO study demonstrates improved procedure efficiencies and valve performance Pooled...

Additional GI Genius™ units installed at VA facilities, providing enhanced colonoscopy care and advancing AI-powered diagnostics for veterans

Endoflip™ is an advanced diagnostic tool that can help expedite accurate diagnosis of esophageal motility disorders, conditions often missed during endoscopies.^1,2

Collaboration with health technology company Tempus seeks to identify causes for undertreatment of minority patients with heart valve disease who may benefit from minimally invasive therapies

With its Meal Detection Technology™* and autocorrections every 5 minutes, Medtronic is expanding outcomes to populations in Asia and empowering patients to achieve greater glycemic control, especially during mealtimes.

New data from Australia, Japan, India, Singapore, Hong Kong, and South Korea demonstrates the MiniMed™ 780G is driving consistent clinical outcomes in diabetes management.

Comparative data and systematic literature review released at VIVA 2024 show breadth and depth of data supporting atherectomy as a treatment for peripheral arterial disease

Newest-generation Evolut TAVI system builds on its market leading valve performance and durability with enhanced coronary access

Funding to support organisations with a mission to improve health outcomes

The VT research will provide important clinical evidence in an underserved patient population

Survey of 1,000 U.S. surgeons finds digital tech like AI and live streaming crucial to closing surgical care gaps in under-resourced regions.

Global expansion of the Avalus Ultra valve continues in Western Europe while company highlights robust, innovative Cardiac Surgery portfolio at EACTS in Lisbon

Bolsters Medtronic Cardiac Surgery’s comprehensive portfolio of cardiac surgical and respiratory innovation